Review Article

Split Viewer

Korean J Hematol 2011; 46(2):

Published online June 21, 2011

https://doi.org/10.5045/kjh.2011.46.2.69

© The Korean Society of Hematology

Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD

Ok S. Shin1*, and Jason B. Harris2,3

1Department of Medical Life Science Research, The Catholic University of Korea, School of Medicine, Seoul, Korea.

2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

3Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Correspondence to : Correspondence to Ok S. Shin, Ph.D. Department of Medical Life Science Research, The Catholic University of Korea, School of Medicine, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-7252, Fax: +82-2-591-3994, oshin@catholic.ac.kr

Received: May 25, 2011; Revised: June 13, 2011; Accepted: June 13, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Graft-versus-host disease (GVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT) and this occurs as donor T lymphocytes, activated by recipient antigen presenting cells (APC), attack the host tissues or organs. This APC activation is a crucial initial step of influencing the outcome of GVHD and is mediated by innate immune signaling. Toll-like receptors (TLRs) and nucleotide binding oligomerization domain (NOD)-like receptors (NLRs) are important components of innate immunity; both families of receptors are known for sensing various microbial ligands or danger signals. Signaling through TLRs/NLRs regulate activities of APCs, through phagocytosis, cytokine and chemokine release, delivery of APCs from peripheral tissues to draining lymph nodes, and antigen presentation. Several TLRs/NLRs have been identified and their ligands and signaling pathways have been described. Recent findings suggest a significant association of TLR/NLR polymorphisms with the increased risk for severe GVHD. Therefore, these TLR/NLR pathways likely contributing to immune response for GVHD may serve as novel therapeutic targets to facilitate allograft tolerance. This review summarizes the role of TLRs/NLRs innate immune receptors and signaling in GVHD pathophysiology.

Keywords Innate immunity, GVHD, Transplantation, TLR, NLR

Article

Review Article

Korean J Hematol 2011; 46(2): 69-79

Published online June 21, 2011 https://doi.org/10.5045/kjh.2011.46.2.69

Copyright © The Korean Society of Hematology.

Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD

Ok S. Shin1*, and Jason B. Harris2,3

1Department of Medical Life Science Research, The Catholic University of Korea, School of Medicine, Seoul, Korea.

2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

3Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Correspondence to: Correspondence to Ok S. Shin, Ph.D. Department of Medical Life Science Research, The Catholic University of Korea, School of Medicine, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-7252, Fax: +82-2-591-3994, oshin@catholic.ac.kr

Received: May 25, 2011; Revised: June 13, 2011; Accepted: June 13, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Graft-versus-host disease (GVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT) and this occurs as donor T lymphocytes, activated by recipient antigen presenting cells (APC), attack the host tissues or organs. This APC activation is a crucial initial step of influencing the outcome of GVHD and is mediated by innate immune signaling. Toll-like receptors (TLRs) and nucleotide binding oligomerization domain (NOD)-like receptors (NLRs) are important components of innate immunity; both families of receptors are known for sensing various microbial ligands or danger signals. Signaling through TLRs/NLRs regulate activities of APCs, through phagocytosis, cytokine and chemokine release, delivery of APCs from peripheral tissues to draining lymph nodes, and antigen presentation. Several TLRs/NLRs have been identified and their ligands and signaling pathways have been described. Recent findings suggest a significant association of TLR/NLR polymorphisms with the increased risk for severe GVHD. Therefore, these TLR/NLR pathways likely contributing to immune response for GVHD may serve as novel therapeutic targets to facilitate allograft tolerance. This review summarizes the role of TLRs/NLRs innate immune receptors and signaling in GVHD pathophysiology.

Keywords: Innate immunity, GVHD, Transplantation, TLR, NLR

Fig 1.

Figure 1.

Toll-like receptor (TLR) signaling pathway. Toll-like receptors (TLRs), except for TLR3, use a MyD88-dependent signaling pathway to induce NF-κB activation. TLR3, (and TLR4), on the other hand, can activate MyD88-independent, TRIF-dependent pathway to induce NF-κB or type I interferon (IFN) activation. MyD88 recruits TRAF6 and members of the IRAK family, leading to the activation of the TAK1 complex. The activated TAK1 complex then activates the IKK complex, consisting of IKKα, IKKβ and NEMO (IKK-γ), which catalyze the phosphorylation of IκB proteins. IκBs are degraded by the proteasome, allowing NF-κB to translocate into the nucleus. Simultaneously, the TAK1 complex activates the MAPK pathway, which results in the phosphorylation and activation of AP-1. NF-κB and AP-1 control inflammatory responses through the induction of inflammatory cytokines. The signaling cascade triggered by TLR3 uses MyD88-independent, TRIF-dependent pathway. TRIF recruits TRAF3, which then interacts with TBK1 and IKKi. These kinases mediate phosphorylation of IRF3. Phosphorylated IRF3 dimerizes and translocates into the nucleus to regulate transcription. TRIF also interacts with TRAF6 and RIP1, which mediate NF-κB activation. Activation of the IRF3, NF-κB and MAPK pathways results in the induction of type I IFN, particularly IFN-β.

Blood Research 2011; 46: 69-79https://doi.org/10.5045/kjh.2011.46.2.69

Fig 2.

Figure 2.

NOD-like receptor (NLR) family and inflammasome. NOD1/2 sense peptidoglycan fragments (iE-DAP and MDP) respectively and activate signaling pathways via the serine/threonine RIP2 kinase through CARD-CARD homophilic interactions. Once activated, RIP2 mediates the ubiquitination of NEMO/IKKγ leading to the activation of NF-κB and the production of inflammatory cytokines. In addition to the NF-κB pathway, NOD2 stimulation induces the activation of MAPKs. Several NALPs, NALP1, NALP3, and IPAF, have been identified to sense various ligands and form a cytoplasmic mutiprotein complex called inflammasome. These NALPs recruit the adaptor protein ASC through their PYD domain, which in turn interacts with caspase-1 via a CARD-CARD interaction to form inflammasome. Consequently, inflammasome activation triggers the processing of pro-caspase-1 into a mature form, caspase-1 and active caspase-1 induces cell death and the processing of pro-inflammatory cytokine pro-IL-1β into IL-1β.

Blood Research 2011; 46: 69-79https://doi.org/10.5045/kjh.2011.46.2.69

Fig 3.

Figure 3.

Potential role of TLRs/NLRs in GVHD. GVHD occurs as a result of donor T lymphocyte activation reacting to antigens presented by recipient APCs. Recipient APCs, such as dendritic cells and macrophages, recognize PAMPs and DAMPs via TLRs/NLRs. Microbial pathogens or danger signals can be engulfed by phagocyotsis/endocytosis or through unidentified mechanisms, activate TLRs/NLRs on APCs. The ligation of TLRs leads to the maturation of APCs at the inflammatory site and enhances expression of co-stimulatory molecules and pro-inflammatory cytokines. This leads to a consequent migration of APCs to the draining lymph nodes. There, the APCs present alloantigens to naïve T cells, resulting in T cell activation and expansion. Activated T cells migrate back to the allograft and carry out their effector functions by attacking the graft. Thus, TLRs/NLRs-mediated antigen presentation may indirectly influence the alloreactivity of T cells or TLRs/NLRs may have a direct effect on T cells, thereby enhancing GVHD.

Blood Research 2011; 46: 69-79https://doi.org/10.5045/kjh.2011.46.2.69
Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download